158 related articles for article (PubMed ID: 35748799)
1. Epigallocatechin gallate for Parkinson's disease.
Sergi CM
Clin Exp Pharmacol Physiol; 2022 Oct; 49(10):1029-1041. PubMed ID: 35748799
[TBL] [Abstract][Full Text] [Related]
2. Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease.
Jurado-Coronel JC; Ávila-Rodriguez M; Echeverria V; Hidalgo OA; Gonzalez J; Aliev G; Barreto GE
CNS Neurol Disord Drug Targets; 2016; 15(3):292-300. PubMed ID: 26831259
[TBL] [Abstract][Full Text] [Related]
3. Tea Polyphenols in Parkinson's Disease.
Caruana M; Vassallo N
Adv Exp Med Biol; 2015; 863():117-37. PubMed ID: 26092629
[TBL] [Abstract][Full Text] [Related]
4. Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases.
Gonçalves PB; Sodero ACR; Cordeiro Y
Biomolecules; 2021 May; 11(5):. PubMed ID: 34065606
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin-3-Gallate Protects and Prevents Paraquat-Induced Oxidative Stress and Neurodegeneration in Knockdown dj-1-β Drosophila melanogaster.
Martinez-Perez DA; Jimenez-Del-Rio M; Velez-Pardo C
Neurotox Res; 2018 Oct; 34(3):401-416. PubMed ID: 29667128
[TBL] [Abstract][Full Text] [Related]
6. Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG).
Singh NA; Mandal AK; Khan ZA
Nutr J; 2016 Jun; 15(1):60. PubMed ID: 27268025
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson's disease.
Zhou T; Zhu M; Liang Z
Mol Med Rep; 2018 Apr; 17(4):4883-4888. PubMed ID: 29363729
[TBL] [Abstract][Full Text] [Related]
8. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate.
Mandel S; Maor G; Youdim MB
J Mol Neurosci; 2004; 24(3):401-16. PubMed ID: 15655262
[TBL] [Abstract][Full Text] [Related]
9. Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease.
Xicota L; Rodriguez-Morato J; Dierssen M; de la Torre R
Curr Drug Targets; 2017; 18(2):174-195. PubMed ID: 26302801
[TBL] [Abstract][Full Text] [Related]
10. Nutraceuticals in Parkinson's Disease.
Hang L; Basil AH; Lim KL
Neuromolecular Med; 2016 Sep; 18(3):306-21. PubMed ID: 27147525
[TBL] [Abstract][Full Text] [Related]
11. Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism.
Reznichenko L; Kalfon L; Amit T; Youdim MB; Mandel SA
Neurodegener Dis; 2010; 7(4):219-31. PubMed ID: 20197647
[TBL] [Abstract][Full Text] [Related]
12. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases.
Weinreb O; Mandel S; Amit T; Youdim MB
J Nutr Biochem; 2004 Sep; 15(9):506-16. PubMed ID: 15350981
[TBL] [Abstract][Full Text] [Related]
13. Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases.
Pervin M; Unno K; Ohishi T; Tanabe H; Miyoshi N; Nakamura Y
Molecules; 2018 May; 23(6):. PubMed ID: 29843466
[TBL] [Abstract][Full Text] [Related]
14. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases.
Mandel S; Weinreb O; Amit T; Youdim MB
J Neurochem; 2004 Mar; 88(6):1555-69. PubMed ID: 15009657
[TBL] [Abstract][Full Text] [Related]
15. Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate.
Choi JY; Park CS; Kim DJ; Cho MH; Jin BK; Pie JE; Chung WG
Neurotoxicology; 2002 Sep; 23(3):367-74. PubMed ID: 12387363
[TBL] [Abstract][Full Text] [Related]
16. EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson's disease.
Xu Y; Xie M; Xue J; Xiang L; Li Y; Xiao J; Xiao G; Wang HL
FASEB J; 2020 Apr; 34(4):5931-5950. PubMed ID: 32157731
[TBL] [Abstract][Full Text] [Related]
17. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration.
Levites Y; Weinreb O; Maor G; Youdim MB; Mandel S
J Neurochem; 2001 Sep; 78(5):1073-82. PubMed ID: 11553681
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases.
Mandel SA; Amit T; Weinreb O; Reznichenko L; Youdim MB
CNS Neurosci Ther; 2008; 14(4):352-65. PubMed ID: 19040558
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of catechins in an experimental Parkinson's disease model and SK-N-AS cells: evaluation of cell viability, anti-inflammatory and anti-apoptotic effects.
Özduran G; Becer E; Vatansever HS; Yücecan S
Neurol Res; 2022 Jun; 44(6):511-523. PubMed ID: 35000557
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-Gallate, a Promising Molecule for Parkinson's Disease?
Renaud J; Nabavi SF; Daglia M; Nabavi SM; Martinoli MG
Rejuvenation Res; 2015 Jun; 18(3):257-69. PubMed ID: 25625827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
